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Highlighting the palliative care needs of people using drugs  
 
We welcome the call to action for palliative care reform for underserved populations in a recent 
editorial of Collegian (Phillips, Bloomer, & Mills, 2019).  The authors note that the integration of a 
harm reduction philosophy into palliative care services is not always clear and we believe that much 
more can be done to facilitate this.  
Whilst they acknowledge “substance misuse” (sic) as a multi-morbidity we argue that people who 
inject drugs are an underserved population who need to be specifically identified in these reforms. 
Evidence tells us that in the area of health care people using illicit drugs are more stigmatised than 
any other population group (Chan Carusone et al., 2019) and those who are using opiates state that 
they get inadequate pain relief for fear that they are ‘drug seeking’ (McNeil, Kerr, Pauly, Wood, & 
Small, 2016). Stigma is so entrenched that a great deal more than having a patient-centred 
philosophy of care is required (Biancarelli et al., 2019).   This is also supported by evidence that 
shows clinicians fear both under- and over-prescribing pain medication to people using opiates 
(Witham, Yarwood, Wright, & Galvani, 2019).  By explicitly focusing attention on the needs of people 
who use illicit drugs we can do more to ensure they are considered an important part of this reform 
agenda. 
Recent work in the area (Galvani, 2019) outline a number of issues which need to be considered if 
we are to be in a position to offer best practice advanced care planning for people who use drugs.  
These include training and education of both substance use professionals and those working in 
palliative and end of life care.  As noted above, multiple levels of overt and covert stigma occur at 
both professional and personal levels. Increasing skills and awareness in this area will be paramount 
to effective support.   
The ‘nothing about us without us’ movement tries to engender a human rights and public health 
centred  approach to HIV and hepatitis C (Jürgens, 2008).  The experience from this will help the 
palliative care sector enormously as this new demographic enters their care. It is an example of 
where the meaningful involvement of the people who are most affected has resulted in some 
important policy changes (Madden & Cavalieri, 2007).  This also highlights how working to reduce  
harm can facilitate the development of policies and practises designed to meet people’s needs but 
putting people front and centre will never be enough.  
Instead the involvement of people who use illicit drugs in the development of healthy ageing 
programs will ensure that access to appropriate palliative care is available when they need it. This is 
as crucial as the nurse-led models of care advocated by Phillips and colleagues.  Incorporating the 
people using services as well as those delivering them into the model of care should maximise the 
chances of improving the quality of palliative and end of life care.   
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